Standout Papers
- Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes (2020)
- Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes (2020)
- Efficacy and Safety of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Added to Ongoing Metformin Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Alone (2006)
- Radioimmunoassay of Prostaglandins Fα, E1 and E2 in Human Plasma (1975)
Immediate Impact
5 by Nobel laureates 4 from Science/Nature 78 standout
Citing Papers
Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes
2025 Standout
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
2023 Standout
Works of B Charbonnel being referenced
Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes
2020 Standout
Efficacy and Safety of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Added to Ongoing Metformin Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Alone
2006 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| B Charbonnel | 6864 | 3248 | 2763 | 236 | 9.4k | |
| Russell Scott | 5727 | 2616 | 4665 | 237 | 11.1k | |
| Guntram Schernthaner | 6064 | 2851 | 2636 | 223 | 10.6k | |
| Boaz Hirshberg | 6032 | 2656 | 3478 | 118 | 8.5k | |
| Jorge Luiz Gross | 5592 | 2270 | 2183 | 235 | 10.2k | |
| Lawrence Blonde | 8000 | 3280 | 2827 | 182 | 10.0k | |
| Eberhard Standl | 5815 | 2049 | 2322 | 205 | 8.8k | |
| Zachary T. Bloomgarden | 5684 | 2040 | 2185 | 263 | 9.1k | |
| William C. Duckworth | 7076 | 3740 | 2931 | 198 | 12.7k | |
| Vanita R. Aroda | 6780 | 3070 | 2002 | 164 | 9.5k | |
| Paola Fioretto | 3942 | 1817 | 1981 | 191 | 9.8k |
All Works
Login with ORCID to disown or claim papers
Loading papers...